3 ASX All Ordinaries shares leaping 10% or more today

Three different coloured arrows going up, symbolising a rising share price and record highs.

Three different coloured arrows going up, symbolising a rising share price and record highs.

All Ordinaries Index (ASX: XAO) shares, as a whole, are struggling today.

At the time of writing the 500 ASX shares that make up the All Ordinaries are down a combined 0.5%, with many sliding following the release of the RBA’s Monetary Policy meeting minutes earlier today.

But some companies are bucking that trend, with these three ASX All Ordinaries shares charging higher.

3 ASX All Ordinaries shares leaping higher today

First up we have Strandline Resources Ltd (ASX: STA).

The ASX resource explorer is primarily focused on mineral sands, with projects in Australia and Tanzania. There’s no fresh news out from the company, but that’s not stopping investors from bidding up the price.

Strandline closed yesterday trading at 32 cents per share and is currently trading for 35 cents per share, up 9.5%. At the current price that gives Strandline Resources a market cap of $428 million.

Our second ASX All Ordinaries share galloping higher today on no new price-sensitive news is Qualitas Limited (ASX: QAL), a recent newcomer to the ASX, listing on 16 December 2021.

Shares in the alternative real estate investment manager closed at $1.62 yesterday and are currently trading for $1.78, up 9.9%. That boosts the company’s market cap to $523 million.

Also charging higher…

Also charging higher is clinical-stage biotechnology company Mesoblast Ltd (ASX: MSB).

The ASX All Ordinaries share was up 14% in early morning trade, but has given some of that back. At the time of writing, shares are trading for 93 cents, up 8.2%, giving the company a market cap of $596 million.

Unlike the other two big gainers, Mesoblast did release fresh news this morning, citing clinical progress with its rexlemestrocel-L product candidate.

As my Fool colleague, James Mickleboro reported:

Rexlemestrocel-L delivered an improvement in left ventricular ejection fraction (LVEF) at 12 months after a single intervention in the 565-patient randomised controlled trial in New York Heart Association (NYHA) class II/III chronic heart failure (CHF) with reduced ejection fraction (HFrEF).

The post 3 ASX All Ordinaries shares leaping 10% or more today appeared first on The Motley Fool Australia.

“The worst thing you can do is nothing”

Motley Fool Chief Investment Officer says right now is not the time to sit on your hands…
As inflation eats away at cash balances Scott Phillips reveals three stocks for investors to consider that could help fight rising prices…
… And Mesoblast Limited isn’t one of them.

Learn More
*Returns as of July 1 2022

(function() {
function setButtonColorDefaults(param, property, defaultValue) {
if( !param || !param.includes(‘#’)) {
var button = document.getElementsByClassName(“pitch-snippet”)[0].getElementsByClassName(“pitch-button”)[0];
button.style[property] = defaultValue;
}
}

setButtonColorDefaults(“#43B02A”, ‘background’, ‘#5FA85D’);
setButtonColorDefaults(“#43B02A”, ‘border-color’, ‘#43A24A’);
setButtonColorDefaults(“#FFF”, ‘color’, ‘#fff’);
})()

More reading

Motley Fool contributor Bernd Struben has no position in any of the stocks mentioned. The Motley Fool Australia’s parent company Motley Fool Holdings Inc. has no position in any of the stocks mentioned. The Motley Fool Australia has no position in any of the stocks mentioned. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Scott Phillips.

from The Motley Fool Australia https://ift.tt/N1dko4j

Leave a Reply

Fill in your details below or click an icon to log in:

WordPress.com Logo

You are commenting using your WordPress.com account. Log Out /  Change )

Twitter picture

You are commenting using your Twitter account. Log Out /  Change )

Facebook photo

You are commenting using your Facebook account. Log Out /  Change )

Connecting to %s